{
  "paper": {
    "paper_id": "30448613_table3",
    "pmcid": "",
    "pmid": "30448613",
    "pdf": "/Users/sherryhuang/advp_curator/paper/nihms-1510343.pdf",
    "table_input": "/Users/sherryhuang/advp_curator/table_from_link/30448613_table3.xlsx",
    "full_text_source": "pdfplumber",
    "id_evidence": "PMID inferred from source filename -> 30448613"
  },
  "table_source_errors": [],
  "global_field_audit": [
    {
      "field": "Stage",
      "value": "Meta-analysis",
      "confidence": 0.8,
      "evidence": "an A, Nothen MM, Graff C, Psaty BM, Jones L, Haines JL, Holmans PA, Lathrop M, Pericak-Vance MA, Launer LJ, Farrer LA, van Duijn CM, Van Broeckhoven C, Moskvina V, Seshadri S, Williams J, Schellenberg GD, Amouyel P 2013 Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer’s disease. Nat Genet 45(12), 1452–8. doi: 10.1038/ng.2802. [PubMed: 24162737] Leek JT, Johnson WE, Parker HS, Jaffe AE, Storey JD 2012 The sva pa",
      "rule": "found meta-analysis cues",
      "needs_review": false
    },
    {
      "field": "Analyses type",
      "value": "Imaging",
      "confidence": 0.7,
      "evidence": "dni.loni.usc.edu). The ADNI was launched in 2003 as a public-private partnership, led by Principal Investigator Michael W. Weiner, MD. The primary goal of ADNI has been to test whether serial magnetic resonance imaging (MRI), positron emission tomography (PET), other biological markers, and clinical and neuropsychological assessment can be combined to measure the progression of mild cognitive impairment (MCI) and early Alzheimer’s disease ",
      "rule": "matched association keywords -> Imaging",
      "needs_review": true
    },
    {
      "field": "Model type",
      "value": "logistic regression (with covariates)",
      "confidence": 0.75,
      "evidence": "iduals of European ancestry (1000 Genomes EUR) (1000 Genomes Project Consortium, 2010). In the discovery analysis for common SNPs in ADGC, we performed association tests under an additive mode of inheritance (MOI) using logistic regression adjusted for age at last visit or death, sex, and the top five principal components (PCs) computed in PLINK v1.90a (Chang, et al., 2015,Purcell, et al., 2007). The coding SNPs Neurobiol Aging. Author manuscri",
      "rule": "model family + covariate cues",
      "needs_review": true
    },
    {
      "field": "Imputation_simple2",
      "value": "1000G;HRC",
      "confidence": 0.65,
      "evidence": "mposed of 18 cohorts from the Alzheimer’s Disease Genetic Consortium (ADGC) and six cohorts from the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium (Beecham, et al., 2017). We also used imputed SNP data (Supplementary Method) from the ADGC comprising 23 different cohorts (Supplementary Table 2). From these sources, there were 28,730 unrelated subjects with imputed GWAS SNP data in ADGC and 10,913 unrelated s",
      "rule": "panel keyword detection (TOPMed/HRC/1000G) (multiple panels; table-specific mapping unclear)",
      "needs_review": true
    },
    {
      "field": "Population",
      "value": "European ancestry",
      "confidence": 0.75,
      "evidence": " showing strong (r2 ≥ 0.8) or moderate (0.4 ≤ r2 < 0.8) LD with each of the IGAP SNPs by using 1000 Genomes Project Phase 3 in < 0.8) LD with each of the IGAP SNPs by using 1000 Genomes Project Phase 3 in individuals of European ancestry (1000 Genomes EUR) (1000 Genomes Project individuals of European ancestry (1000 Genomes EUR) (1000 Genomes Project Consortium, 2010). In the discovery analysis for common SNPs in ADGC, we performed Consortium, ",
      "rule": "section-aware population keyword",
      "needs_review": true
    },
    {
      "field": "Sample size",
      "value": "74046",
      "confidence": 0.7,
      "evidence": "cs of Alzheimer’s Project (IGAP), which individuals was the International Genomics of Alzheimer’s Project (IGAP), which capitalized on a large, multicenter study design to include 74,046 individuals (Lambert, et capitalized on a large, multicenter study design to include 74,046 individuals (Lambert, et al., 2013). This study extended associations between the AD phenotype and ",
      "rule": "section-aware sample size extraction",
      "needs_review": true
    }
  ],
  "record_field_audit": [
    {
      "RecordID": "30448613_table3_R00001",
      "fields": [
        {
          "field": "Name",
          "value": "rs8093731",
          "confidence": 0.9,
          "evidence": "Row text: rs8093731 | DSG2 | ILMN_23 80779 | DLGAP1 | FCTX | 0.770 | 1.36×10−8\n[column_mapping] {\"IGAP SNP\": {\"reference_col\": \"Cohort\", \"score\": 0.4, \"needs_review\": false, \"match_hint\": \"IGAP SNP\"}, \"Closest  gene\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.3",
          "rule": "table row rsID extraction",
          "needs_review": false
        },
        {
          "field": "P-value",
          "value": 1.3600000000000001e-08,
          "confidence": 0.7,
          "evidence": "Row text: rs8093731 | DSG2 | ILMN_23 80779 | DLGAP1 | FCTX | 0.770 | 1.36×10−8\n[column_mapping] {\"IGAP SNP\": {\"reference_col\": \"Cohort\", \"score\": 0.4, \"needs_review\": false, \"match_hint\": \"IGAP SNP\"}, \"Closest  gene\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.3",
          "rule": "table row p-value parsing",
          "needs_review": false
        },
        {
          "field": "EffectSize(altvsref)",
          "value": 0.77,
          "confidence": 0.65,
          "evidence": "Row text: rs8093731 | DSG2 | ILMN_23 80779 | DLGAP1 | FCTX | 0.770 | 1.36×10−8\n[column_mapping] {\"IGAP SNP\": {\"reference_col\": \"Cohort\", \"score\": 0.4, \"needs_review\": false, \"match_hint\": \"IGAP SNP\"}, \"Closest  gene\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.3",
          "rule": "table row effect parsing",
          "needs_review": false
        },
        {
          "field": "Stage",
          "value": "Meta-analysis",
          "confidence": 0.8,
          "evidence": "an A, Nothen MM, Graff C, Psaty BM, Jones L, Haines JL, Holmans PA, Lathrop M, Pericak-Vance MA, Launer LJ, Farrer LA, van Duijn CM, Van Broeckhoven C, Moskvina V, Seshadri S, Williams J, Schellenberg GD, Amouyel P 2013 Meta-analysis of 74,046 individuals iden",
          "rule": "found meta-analysis cues",
          "needs_review": false
        },
        {
          "field": "Model type",
          "value": "logistic regression (with covariates)",
          "confidence": 0.75,
          "evidence": "iduals of European ancestry (1000 Genomes EUR) (1000 Genomes Project Consortium, 2010). In the discovery analysis for common SNPs in ADGC, we performed association tests under an additive mode of inheritance (MOI) using logistic regression adjusted for age at ",
          "rule": "model family + covariate cues",
          "needs_review": true
        },
        {
          "field": "Imputation_simple2",
          "value": "HRC;1000G",
          "confidence": 0.65,
          "evidence": "mposed of 18 cohorts from the Alzheimer’s Disease Genetic Consortium (ADGC) and six cohorts from the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium (Beecham, et al., 2017). We also used imputed SNP data (Supplementary Method) ",
          "rule": "panel keyword detection (TOPMed/HRC/1000G) (multiple panels; table-specific mapping unclear)",
          "needs_review": true
        },
        {
          "field": "Population",
          "value": "European ancestry",
          "confidence": 0.75,
          "evidence": " showing strong (r2 ≥ 0.8) or moderate (0.4 ≤ r2 < 0.8) LD with each of the IGAP SNPs by using 1000 Genomes Project Phase 3 in < 0.8) LD with each of the IGAP SNPs by using 1000 Genomes Project Phase 3 in individuals of European ancestry (1000 Genomes EUR) (10",
          "rule": "section-aware population keyword",
          "needs_review": true
        },
        {
          "field": "Sample size",
          "value": "74046",
          "confidence": 0.7,
          "evidence": "cs of Alzheimer’s Project (IGAP), which individuals was the International Genomics of Alzheimer’s Project (IGAP), which capitalized on a large, multicenter study design to include 74,046 individuals (Lambert, et capitalized on a large, multicenter study design",
          "rule": "section-aware sample size extraction",
          "needs_review": true
        },
        {
          "field": "Cohort",
          "value": "IGAP",
          "confidence": 0.8,
          "evidence": "Row text: rs8093731 | DSG2 | ILMN_23 80779 | DLGAP1 | FCTX | 0.770 | 1.36×10−8\n[column_mapping] {\"IGAP SNP\": {\"reference_col\": \"Cohort\", \"score\": 0.4, \"needs_review\": false, \"match_hint\": \"IGAP SNP\"}, \"Closest  gene\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.3",
          "rule": "cohort keyword mapping",
          "needs_review": false
        }
      ]
    },
    {
      "RecordID": "30448613_table3_R00002",
      "fields": [
        {
          "field": "Name",
          "value": "rs8093731",
          "confidence": 0.9,
          "evidence": "Row text:  |  | ILMN_1783168 | NETO1 | FCTX | 0.706 | 1.11×10−5\n[column_mapping] {\"IGAP SNP\": {\"reference_col\": \"Cohort\", \"score\": 0.4, \"needs_review\": false, \"match_hint\": \"IGAP SNP\"}, \"Closest  gene\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.3333, \"needs_rev",
          "rule": "table row rsID extraction",
          "needs_review": false
        },
        {
          "field": "P-value",
          "value": 1.1100000000000002e-05,
          "confidence": 0.7,
          "evidence": "Row text:  |  | ILMN_1783168 | NETO1 | FCTX | 0.706 | 1.11×10−5\n[column_mapping] {\"IGAP SNP\": {\"reference_col\": \"Cohort\", \"score\": 0.4, \"needs_review\": false, \"match_hint\": \"IGAP SNP\"}, \"Closest  gene\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.3333, \"needs_rev",
          "rule": "table row p-value parsing",
          "needs_review": false
        },
        {
          "field": "EffectSize(altvsref)",
          "value": 0.706,
          "confidence": 0.65,
          "evidence": "Row text:  |  | ILMN_1783168 | NETO1 | FCTX | 0.706 | 1.11×10−5\n[column_mapping] {\"IGAP SNP\": {\"reference_col\": \"Cohort\", \"score\": 0.4, \"needs_review\": false, \"match_hint\": \"IGAP SNP\"}, \"Closest  gene\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.3333, \"needs_rev",
          "rule": "table row effect parsing",
          "needs_review": false
        },
        {
          "field": "Stage",
          "value": "Meta-analysis",
          "confidence": 0.8,
          "evidence": "an A, Nothen MM, Graff C, Psaty BM, Jones L, Haines JL, Holmans PA, Lathrop M, Pericak-Vance MA, Launer LJ, Farrer LA, van Duijn CM, Van Broeckhoven C, Moskvina V, Seshadri S, Williams J, Schellenberg GD, Amouyel P 2013 Meta-analysis of 74,046 individuals iden",
          "rule": "found meta-analysis cues",
          "needs_review": false
        },
        {
          "field": "Model type",
          "value": "logistic regression (with covariates)",
          "confidence": 0.75,
          "evidence": "iduals of European ancestry (1000 Genomes EUR) (1000 Genomes Project Consortium, 2010). In the discovery analysis for common SNPs in ADGC, we performed association tests under an additive mode of inheritance (MOI) using logistic regression adjusted for age at ",
          "rule": "model family + covariate cues",
          "needs_review": true
        },
        {
          "field": "Imputation_simple2",
          "value": "HRC;1000G",
          "confidence": 0.65,
          "evidence": "mposed of 18 cohorts from the Alzheimer’s Disease Genetic Consortium (ADGC) and six cohorts from the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium (Beecham, et al., 2017). We also used imputed SNP data (Supplementary Method) ",
          "rule": "panel keyword detection (TOPMed/HRC/1000G) (multiple panels; table-specific mapping unclear)",
          "needs_review": true
        },
        {
          "field": "Population",
          "value": "European ancestry",
          "confidence": 0.75,
          "evidence": " showing strong (r2 ≥ 0.8) or moderate (0.4 ≤ r2 < 0.8) LD with each of the IGAP SNPs by using 1000 Genomes Project Phase 3 in < 0.8) LD with each of the IGAP SNPs by using 1000 Genomes Project Phase 3 in individuals of European ancestry (1000 Genomes EUR) (10",
          "rule": "section-aware population keyword",
          "needs_review": true
        },
        {
          "field": "Sample size",
          "value": "74046",
          "confidence": 0.7,
          "evidence": "cs of Alzheimer’s Project (IGAP), which individuals was the International Genomics of Alzheimer’s Project (IGAP), which capitalized on a large, multicenter study design to include 74,046 individuals (Lambert, et capitalized on a large, multicenter study design",
          "rule": "section-aware sample size extraction",
          "needs_review": true
        },
        {
          "field": "Cohort",
          "value": "IGAP",
          "confidence": 0.8,
          "evidence": "Row text:  |  | ILMN_1783168 | NETO1 | FCTX | 0.706 | 1.11×10−5\n[column_mapping] {\"IGAP SNP\": {\"reference_col\": \"Cohort\", \"score\": 0.4, \"needs_review\": false, \"match_hint\": \"IGAP SNP\"}, \"Closest  gene\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.3333, \"needs_rev",
          "rule": "cohort keyword mapping",
          "needs_review": false
        }
      ]
    },
    {
      "RecordID": "30448613_table3_R00003",
      "fields": [
        {
          "field": "Name",
          "value": "rs4147929",
          "confidence": 0.9,
          "evidence": "Row text: rs4147929 | ABCA7 | t3862068 | EID2B | FCTX | 0.259 | 3.94×10−6\n[column_mapping] {\"IGAP SNP\": {\"reference_col\": \"Cohort\", \"score\": 0.4, \"needs_review\": false, \"match_hint\": \"IGAP SNP\"}, \"Closest  gene\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.3333, ",
          "rule": "table row rsID extraction",
          "needs_review": false
        },
        {
          "field": "P-value",
          "value": 3.9399999999999995e-06,
          "confidence": 0.7,
          "evidence": "Row text: rs4147929 | ABCA7 | t3862068 | EID2B | FCTX | 0.259 | 3.94×10−6\n[column_mapping] {\"IGAP SNP\": {\"reference_col\": \"Cohort\", \"score\": 0.4, \"needs_review\": false, \"match_hint\": \"IGAP SNP\"}, \"Closest  gene\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.3333, ",
          "rule": "table row p-value parsing",
          "needs_review": false
        },
        {
          "field": "EffectSize(altvsref)",
          "value": 0.259,
          "confidence": 0.65,
          "evidence": "Row text: rs4147929 | ABCA7 | t3862068 | EID2B | FCTX | 0.259 | 3.94×10−6\n[column_mapping] {\"IGAP SNP\": {\"reference_col\": \"Cohort\", \"score\": 0.4, \"needs_review\": false, \"match_hint\": \"IGAP SNP\"}, \"Closest  gene\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.3333, ",
          "rule": "table row effect parsing",
          "needs_review": false
        },
        {
          "field": "Stage",
          "value": "Meta-analysis",
          "confidence": 0.8,
          "evidence": "an A, Nothen MM, Graff C, Psaty BM, Jones L, Haines JL, Holmans PA, Lathrop M, Pericak-Vance MA, Launer LJ, Farrer LA, van Duijn CM, Van Broeckhoven C, Moskvina V, Seshadri S, Williams J, Schellenberg GD, Amouyel P 2013 Meta-analysis of 74,046 individuals iden",
          "rule": "found meta-analysis cues",
          "needs_review": false
        },
        {
          "field": "Model type",
          "value": "logistic regression (with covariates)",
          "confidence": 0.75,
          "evidence": "iduals of European ancestry (1000 Genomes EUR) (1000 Genomes Project Consortium, 2010). In the discovery analysis for common SNPs in ADGC, we performed association tests under an additive mode of inheritance (MOI) using logistic regression adjusted for age at ",
          "rule": "model family + covariate cues",
          "needs_review": true
        },
        {
          "field": "Imputation_simple2",
          "value": "HRC;1000G",
          "confidence": 0.65,
          "evidence": "mposed of 18 cohorts from the Alzheimer’s Disease Genetic Consortium (ADGC) and six cohorts from the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium (Beecham, et al., 2017). We also used imputed SNP data (Supplementary Method) ",
          "rule": "panel keyword detection (TOPMed/HRC/1000G) (multiple panels; table-specific mapping unclear)",
          "needs_review": true
        },
        {
          "field": "Population",
          "value": "European ancestry",
          "confidence": 0.75,
          "evidence": " showing strong (r2 ≥ 0.8) or moderate (0.4 ≤ r2 < 0.8) LD with each of the IGAP SNPs by using 1000 Genomes Project Phase 3 in < 0.8) LD with each of the IGAP SNPs by using 1000 Genomes Project Phase 3 in individuals of European ancestry (1000 Genomes EUR) (10",
          "rule": "section-aware population keyword",
          "needs_review": true
        },
        {
          "field": "Sample size",
          "value": "74046",
          "confidence": 0.7,
          "evidence": "cs of Alzheimer’s Project (IGAP), which individuals was the International Genomics of Alzheimer’s Project (IGAP), which capitalized on a large, multicenter study design to include 74,046 individuals (Lambert, et capitalized on a large, multicenter study design",
          "rule": "section-aware sample size extraction",
          "needs_review": true
        },
        {
          "field": "Cohort",
          "value": "IGAP",
          "confidence": 0.8,
          "evidence": "Row text: rs4147929 | ABCA7 | t3862068 | EID2B | FCTX | 0.259 | 3.94×10−6\n[column_mapping] {\"IGAP SNP\": {\"reference_col\": \"Cohort\", \"score\": 0.4, \"needs_review\": false, \"match_hint\": \"IGAP SNP\"}, \"Closest  gene\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.3333, ",
          "rule": "cohort keyword mapping",
          "needs_review": false
        }
      ]
    },
    {
      "RecordID": "30448613_table3_R00004",
      "fields": [
        {
          "field": "Name",
          "value": "rs10948363",
          "confidence": 0.9,
          "evidence": "Row text: rs10948363 | CD2AP | t2969159 | AK9 | FCTX | 0.343 | 1.64×10−5\n[column_mapping] {\"IGAP SNP\": {\"reference_col\": \"Cohort\", \"score\": 0.4, \"needs_review\": false, \"match_hint\": \"IGAP SNP\"}, \"Closest  gene\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.3333, \"",
          "rule": "table row rsID extraction",
          "needs_review": false
        },
        {
          "field": "P-value",
          "value": 1.64e-05,
          "confidence": 0.7,
          "evidence": "Row text: rs10948363 | CD2AP | t2969159 | AK9 | FCTX | 0.343 | 1.64×10−5\n[column_mapping] {\"IGAP SNP\": {\"reference_col\": \"Cohort\", \"score\": 0.4, \"needs_review\": false, \"match_hint\": \"IGAP SNP\"}, \"Closest  gene\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.3333, \"",
          "rule": "table row p-value parsing",
          "needs_review": false
        },
        {
          "field": "EffectSize(altvsref)",
          "value": 0.343,
          "confidence": 0.65,
          "evidence": "Row text: rs10948363 | CD2AP | t2969159 | AK9 | FCTX | 0.343 | 1.64×10−5\n[column_mapping] {\"IGAP SNP\": {\"reference_col\": \"Cohort\", \"score\": 0.4, \"needs_review\": false, \"match_hint\": \"IGAP SNP\"}, \"Closest  gene\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.3333, \"",
          "rule": "table row effect parsing",
          "needs_review": false
        },
        {
          "field": "Stage",
          "value": "Meta-analysis",
          "confidence": 0.8,
          "evidence": "an A, Nothen MM, Graff C, Psaty BM, Jones L, Haines JL, Holmans PA, Lathrop M, Pericak-Vance MA, Launer LJ, Farrer LA, van Duijn CM, Van Broeckhoven C, Moskvina V, Seshadri S, Williams J, Schellenberg GD, Amouyel P 2013 Meta-analysis of 74,046 individuals iden",
          "rule": "found meta-analysis cues",
          "needs_review": false
        },
        {
          "field": "Model type",
          "value": "logistic regression (with covariates)",
          "confidence": 0.75,
          "evidence": "iduals of European ancestry (1000 Genomes EUR) (1000 Genomes Project Consortium, 2010). In the discovery analysis for common SNPs in ADGC, we performed association tests under an additive mode of inheritance (MOI) using logistic regression adjusted for age at ",
          "rule": "model family + covariate cues",
          "needs_review": true
        },
        {
          "field": "Imputation_simple2",
          "value": "HRC;1000G",
          "confidence": 0.65,
          "evidence": "mposed of 18 cohorts from the Alzheimer’s Disease Genetic Consortium (ADGC) and six cohorts from the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium (Beecham, et al., 2017). We also used imputed SNP data (Supplementary Method) ",
          "rule": "panel keyword detection (TOPMed/HRC/1000G) (multiple panels; table-specific mapping unclear)",
          "needs_review": true
        },
        {
          "field": "Population",
          "value": "European ancestry",
          "confidence": 0.75,
          "evidence": " showing strong (r2 ≥ 0.8) or moderate (0.4 ≤ r2 < 0.8) LD with each of the IGAP SNPs by using 1000 Genomes Project Phase 3 in < 0.8) LD with each of the IGAP SNPs by using 1000 Genomes Project Phase 3 in individuals of European ancestry (1000 Genomes EUR) (10",
          "rule": "section-aware population keyword",
          "needs_review": true
        },
        {
          "field": "Sample size",
          "value": "74046",
          "confidence": 0.7,
          "evidence": "cs of Alzheimer’s Project (IGAP), which individuals was the International Genomics of Alzheimer’s Project (IGAP), which capitalized on a large, multicenter study design to include 74,046 individuals (Lambert, et capitalized on a large, multicenter study design",
          "rule": "section-aware sample size extraction",
          "needs_review": true
        },
        {
          "field": "Cohort",
          "value": "IGAP",
          "confidence": 0.8,
          "evidence": "Row text: rs10948363 | CD2AP | t2969159 | AK9 | FCTX | 0.343 | 1.64×10−5\n[column_mapping] {\"IGAP SNP\": {\"reference_col\": \"Cohort\", \"score\": 0.4, \"needs_review\": false, \"match_hint\": \"IGAP SNP\"}, \"Closest  gene\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.3333, \"",
          "rule": "cohort keyword mapping",
          "needs_review": false
        }
      ]
    },
    {
      "RecordID": "30448613_table3_R00005",
      "fields": [
        {
          "field": "Name",
          "value": "rs3865444",
          "confidence": 0.9,
          "evidence": "Row text: rs3865444 | CD33 | t3822216 | IER2 | TCTX | -0.255 | 1.96×10−5\n[column_mapping] {\"IGAP SNP\": {\"reference_col\": \"Cohort\", \"score\": 0.4, \"needs_review\": false, \"match_hint\": \"IGAP SNP\"}, \"Closest  gene\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.3333, \"",
          "rule": "table row rsID extraction",
          "needs_review": false
        },
        {
          "field": "P-value",
          "value": 1.9600000000000002e-05,
          "confidence": 0.7,
          "evidence": "Row text: rs3865444 | CD33 | t3822216 | IER2 | TCTX | -0.255 | 1.96×10−5\n[column_mapping] {\"IGAP SNP\": {\"reference_col\": \"Cohort\", \"score\": 0.4, \"needs_review\": false, \"match_hint\": \"IGAP SNP\"}, \"Closest  gene\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.3333, \"",
          "rule": "table row p-value parsing",
          "needs_review": false
        },
        {
          "field": "EffectSize(altvsref)",
          "value": -0.255,
          "confidence": 0.65,
          "evidence": "Row text: rs3865444 | CD33 | t3822216 | IER2 | TCTX | -0.255 | 1.96×10−5\n[column_mapping] {\"IGAP SNP\": {\"reference_col\": \"Cohort\", \"score\": 0.4, \"needs_review\": false, \"match_hint\": \"IGAP SNP\"}, \"Closest  gene\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.3333, \"",
          "rule": "table row effect parsing",
          "needs_review": false
        },
        {
          "field": "Stage",
          "value": "Meta-analysis",
          "confidence": 0.8,
          "evidence": "an A, Nothen MM, Graff C, Psaty BM, Jones L, Haines JL, Holmans PA, Lathrop M, Pericak-Vance MA, Launer LJ, Farrer LA, van Duijn CM, Van Broeckhoven C, Moskvina V, Seshadri S, Williams J, Schellenberg GD, Amouyel P 2013 Meta-analysis of 74,046 individuals iden",
          "rule": "found meta-analysis cues",
          "needs_review": false
        },
        {
          "field": "Model type",
          "value": "logistic regression (with covariates)",
          "confidence": 0.75,
          "evidence": "iduals of European ancestry (1000 Genomes EUR) (1000 Genomes Project Consortium, 2010). In the discovery analysis for common SNPs in ADGC, we performed association tests under an additive mode of inheritance (MOI) using logistic regression adjusted for age at ",
          "rule": "model family + covariate cues",
          "needs_review": true
        },
        {
          "field": "Imputation_simple2",
          "value": "HRC;1000G",
          "confidence": 0.65,
          "evidence": "mposed of 18 cohorts from the Alzheimer’s Disease Genetic Consortium (ADGC) and six cohorts from the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium (Beecham, et al., 2017). We also used imputed SNP data (Supplementary Method) ",
          "rule": "panel keyword detection (TOPMed/HRC/1000G) (multiple panels; table-specific mapping unclear)",
          "needs_review": true
        },
        {
          "field": "Population",
          "value": "European ancestry",
          "confidence": 0.75,
          "evidence": " showing strong (r2 ≥ 0.8) or moderate (0.4 ≤ r2 < 0.8) LD with each of the IGAP SNPs by using 1000 Genomes Project Phase 3 in < 0.8) LD with each of the IGAP SNPs by using 1000 Genomes Project Phase 3 in individuals of European ancestry (1000 Genomes EUR) (10",
          "rule": "section-aware population keyword",
          "needs_review": true
        },
        {
          "field": "Sample size",
          "value": "74046",
          "confidence": 0.7,
          "evidence": "cs of Alzheimer’s Project (IGAP), which individuals was the International Genomics of Alzheimer’s Project (IGAP), which capitalized on a large, multicenter study design to include 74,046 individuals (Lambert, et capitalized on a large, multicenter study design",
          "rule": "section-aware sample size extraction",
          "needs_review": true
        },
        {
          "field": "Cohort",
          "value": "IGAP",
          "confidence": 0.8,
          "evidence": "Row text: rs3865444 | CD33 | t3822216 | IER2 | TCTX | -0.255 | 1.96×10−5\n[column_mapping] {\"IGAP SNP\": {\"reference_col\": \"Cohort\", \"score\": 0.4, \"needs_review\": false, \"match_hint\": \"IGAP SNP\"}, \"Closest  gene\": {\"reference_col\": \"UNMAPPED\", \"score\": 0.3333, \"",
          "rule": "cohort keyword mapping",
          "needs_review": false
        }
      ]
    }
  ]
}